Herring roe oil’s potential in psoriasis treatment

In a recent study published in Frontiers in Immunology, researchers investigated the use of herring row oil to treat psoriasis, a non-communicable skin disease. Conventional psoriasis treatment, while effective, is prone to several side effects, necessitating the discovery of novel side-effect-free interventions. Study: Herring roe oil in treatment of psoriasis – influence on immune cells… Continue reading Herring roe oil’s potential in psoriasis treatment

Published
Categorized as Immunology

Experts propose new definition of clinical remission in treatment of asthma

As an increasing number of improved asthma treatments are developed, a greater number of people with asthma are finding their symptoms under control. Their improved status raises an important question for healthcare providers (HCPs) who treat this condition: “What qualifies as clinical remission in the treatment of asthma?” A panel of 11 experts in asthma… Continue reading Experts propose new definition of clinical remission in treatment of asthma

Oxford University study administers first-ever vaccine against Crimean-Congo hemorrhagic fever

AI SummaryA new vaccine for Crimean-Congo hemorrhagic fever (CCHF) is being tested on volunteers for the first time in a clinical trial led by Professor Teresa Lambe at the University of Oxford. The vaccine aims to confirm its safety and understand how individuals develop immunity. If successful, it would be the first step in creating… Continue reading Oxford University study administers first-ever vaccine against Crimean-Congo hemorrhagic fever

Researcher helps boost immune system memory against influenza

Researchers are one step closer to making the T cell army stronger. In a recent study, researchers found that by manipulating one molecular signaling pathway in the T cells that participate in clearing influenza virus in the lungs, the strength and longevity of immunological memory produced can be improved.

Disrupting the Market as Flu Season Approaches – New Review Suggests Questionable Efficacy of OTC Decongestant

AI SummaryThe FDA has been reviewing the effectiveness and safety of oral phenylephrine (PE) as a nasal decongestant. Studies have shown that oral PE did not provide noticeable relief compared to a placebo. New clinical trials also showed that oral PE did not demonstrate significant superiority in relieving nasal congestion. The effectiveness of oral PE… Continue reading Disrupting the Market as Flu Season Approaches – New Review Suggests Questionable Efficacy of OTC Decongestant